Anteris Announces Results for the First Quarter of 2025
13 May 2025 //
GLOBENEWSWIRE
Anteris Technologies: 100 patients treated with DurAVR® THV
31 Mar 2025 //
GLOBENEWSWIRE
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
21 Mar 2025 //
GLOBENEWSWIRE
Anteris Reports 2024 Financial Results and Corporate Update
12 Mar 2025 //
GLOBENEWSWIRE
Anteris To Present At TD Cowen & Barclays Healthcare Conferences
28 Feb 2025 //
GLOBENEWSWIRE
Anteris Technologies provides update on first human study of DurAVR THV
12 Jun 2024 //
PHARMABIZ